A Japanese biopharma venture has surged almost 400% in just over two months on hopes that its vaccine candidate for the coronavirus will be successful.AnGes Inc., a spin-off from Osaka University, …
( read original story …)
The Japan News
A Japanese biopharma venture has surged almost 400% in just over two months on hopes that its vaccine candidate for the coronavirus will be successful.AnGes Inc., a spin-off from Osaka University, …
( read original story …)